In 2026, around ** percent of all forecasted revenue generated by COVID-19 vaccines is expected to be generated by mRNA vaccines. This statistic illustrates the forecasted share of COVID-19 vaccine revenues by technology.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Global Financial Data. (July 14, 2021). Forecasted share of COVID-19 vaccine revenue worldwide in 2021 and 2026, by technology [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 25, 2026, from /statistics/1274553/covid-vaccine-revenue-share-by-technology/
Global Financial Data. "Forecasted share of COVID-19 vaccine revenue worldwide in 2021 and 2026, by technology." Chart. July 14, 2021. ÌÇÐÄÆƽâ°æ. Accessed July 25, 2026. /statistics/1274553/covid-vaccine-revenue-share-by-technology/
Global Financial Data. (2021). Forecasted share of COVID-19 vaccine revenue worldwide in 2021 and 2026, by technology. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 25, 2026. /statistics/1274553/covid-vaccine-revenue-share-by-technology/
Global Financial Data. "Forecasted Share of Covid-19 Vaccine Revenue Worldwide in 2021 and 2026, by Technology." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 14 Jul 2021, /statistics/1274553/covid-vaccine-revenue-share-by-technology/
Global Financial Data, Forecasted share of COVID-19 vaccine revenue worldwide in 2021 and 2026, by technology ÌÇÐÄÆƽâ°æ, /statistics/1274553/covid-vaccine-revenue-share-by-technology/ (last visited July 25, 2026)
Forecasted share of COVID-19 vaccine revenue worldwide in 2021 and 2026, by technology [Graph], Global Financial Data, July 14, 2021. [Online]. Available: /statistics/1274553/covid-vaccine-revenue-share-by-technology/
